Cargando…
Clinical features and outcomes of COVID-19 in patients with rheumatic diseases treated with biological and synthetic targeted therapies
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7307213/ https://www.ncbi.nlm.nih.gov/pubmed/32503857 http://dx.doi.org/10.1136/annrheumdis-2020-217948 |
| _version_ | 1783548769118191616 |
|---|---|
| author | Sanchez-Piedra, Carlos Diaz-Torne, Cesar Manero, Javier Pego-Reigosa, José M Rúa-Figueroa, Íñigo Gonzalez-Gay, Miguel A Gomez-Reino, Juan Alvaro-Gracia, Jose M |
| author_facet | Sanchez-Piedra, Carlos Diaz-Torne, Cesar Manero, Javier Pego-Reigosa, José M Rúa-Figueroa, Íñigo Gonzalez-Gay, Miguel A Gomez-Reino, Juan Alvaro-Gracia, Jose M |
| author_sort | Sanchez-Piedra, Carlos |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7307213 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | BMJ Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-73072132020-06-23 Clinical features and outcomes of COVID-19 in patients with rheumatic diseases treated with biological and synthetic targeted therapies Sanchez-Piedra, Carlos Diaz-Torne, Cesar Manero, Javier Pego-Reigosa, José M Rúa-Figueroa, Íñigo Gonzalez-Gay, Miguel A Gomez-Reino, Juan Alvaro-Gracia, Jose M Ann Rheum Dis Letter BMJ Publishing Group 2020-07 2020-06-05 /pmc/articles/PMC7307213/ /pubmed/32503857 http://dx.doi.org/10.1136/annrheumdis-2020-217948 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. |
| spellingShingle | Letter Sanchez-Piedra, Carlos Diaz-Torne, Cesar Manero, Javier Pego-Reigosa, José M Rúa-Figueroa, Íñigo Gonzalez-Gay, Miguel A Gomez-Reino, Juan Alvaro-Gracia, Jose M Clinical features and outcomes of COVID-19 in patients with rheumatic diseases treated with biological and synthetic targeted therapies |
| title | Clinical features and outcomes of COVID-19 in patients with rheumatic diseases treated with biological and synthetic targeted therapies |
| title_full | Clinical features and outcomes of COVID-19 in patients with rheumatic diseases treated with biological and synthetic targeted therapies |
| title_fullStr | Clinical features and outcomes of COVID-19 in patients with rheumatic diseases treated with biological and synthetic targeted therapies |
| title_full_unstemmed | Clinical features and outcomes of COVID-19 in patients with rheumatic diseases treated with biological and synthetic targeted therapies |
| title_short | Clinical features and outcomes of COVID-19 in patients with rheumatic diseases treated with biological and synthetic targeted therapies |
| title_sort | clinical features and outcomes of covid-19 in patients with rheumatic diseases treated with biological and synthetic targeted therapies |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7307213/ https://www.ncbi.nlm.nih.gov/pubmed/32503857 http://dx.doi.org/10.1136/annrheumdis-2020-217948 |
| work_keys_str_mv | AT sanchezpiedracarlos clinicalfeaturesandoutcomesofcovid19inpatientswithrheumaticdiseasestreatedwithbiologicalandsynthetictargetedtherapies AT diaztornecesar clinicalfeaturesandoutcomesofcovid19inpatientswithrheumaticdiseasestreatedwithbiologicalandsynthetictargetedtherapies AT manerojavier clinicalfeaturesandoutcomesofcovid19inpatientswithrheumaticdiseasestreatedwithbiologicalandsynthetictargetedtherapies AT pegoreigosajosem clinicalfeaturesandoutcomesofcovid19inpatientswithrheumaticdiseasestreatedwithbiologicalandsynthetictargetedtherapies AT ruafigueroainigo clinicalfeaturesandoutcomesofcovid19inpatientswithrheumaticdiseasestreatedwithbiologicalandsynthetictargetedtherapies AT gonzalezgaymiguela clinicalfeaturesandoutcomesofcovid19inpatientswithrheumaticdiseasestreatedwithbiologicalandsynthetictargetedtherapies AT gomezreinojuan clinicalfeaturesandoutcomesofcovid19inpatientswithrheumaticdiseasestreatedwithbiologicalandsynthetictargetedtherapies AT alvarograciajosem clinicalfeaturesandoutcomesofcovid19inpatientswithrheumaticdiseasestreatedwithbiologicalandsynthetictargetedtherapies AT clinicalfeaturesandoutcomesofcovid19inpatientswithrheumaticdiseasestreatedwithbiologicalandsynthetictargetedtherapies |